From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

Back

Doxy-PEP: Everything you need to know! Information Sheet

First published:

June 2025

Last published:

June 2025

Overview

This printable resource provides clients, patients, and the community with comprehensive, easy-to-understand information about Doxy-PEP, including what it is, who it’s for, how it’s taken, its effectiveness, side effects, and cost. This resource was co-created by Health Equity Matters and ASHM.